DRUG · Mapped RxNorm record
Amlodipine besylate
Normalized identity: amlodipine besylateView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
NCT00412113
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Amlodipine besylate/atorvastatin calcium single pill combination
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Amlodipine besylate
Normalized identity: amlodipine besylateView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Amlodipine besylate/atorvastatin calcium single pill combination
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Dyslipidemiaunresolved
Hypertensionunresolved
Interventions
Sponsors & collaborators
Mapped research locations
BirminghamAlabama, United States3CincinnatiOhio, United States2HoustonTexas, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1MiamiFlorida, United States1San AntonioTexas, United States1MinneapolisMinnesota, United States1Oklahoma CityOklahoma, United States1OmahaNebraska, United States1BuffaloNew York, United States1ProvidenceRhode Island, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00412113 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.